(19)
(11) EP 4 771 385 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24860987.7

(22) Date of filing: 29.08.2024
(51) International Patent Classification (IPC): 
G01N 33/50(2006.01)
A61K 38/20(2006.01)
A61K 35/17(2025.01)
G01N 33/92(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 35/17; G01N 33/6896; G01N 2800/52; G01N 2800/2835; A61K 38/2013; A61K 31/192; A61K 31/575; A61K 31/4152; A61K 31/428; A61P 25/28
 
C-Sets:
  1. A61K 31/575, A61K 2300/00;
  2. A61K 31/4152, A61K 2300/00;
  3. A61K 31/428, A61K 2300/00;
  4. A61K 38/2013, A61K 2300/00;
  5. A61K 35/17, A61K 2300/00;
  6. A61K 31/192, A61K 2300/00;

(86) International application number:
PCT/US2024/044320
(87) International publication number:
WO 2025/049671 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 30.08.2023 US 202363535524 P

(71) Applicants:
  • The Methodist Hospital
    Houston, Texas 77030 (US)
  • Coya Therapeutics, Inc.
    Houston, TX 77024 (US)

(72) Inventors:
  • APPEL, Stanley, Hersh
    Houston, TX 77004 (US)
  • BEERS, David, Robert
    Houston, TX 77096 (US)
  • BERMAN, Howard
    Houston, TX 77063 (US)

(74) Representative: Jones Day 
Gewürzmühlstr. 11
80538 München
80538 München (DE)

   


(54) MARKERS OF AMYOTROPHIC LATERAL SCLEROSIS SURVIVAL AND USES THEREOF